DRUG LIFE-CYCLE INSIGHTS ACROSS THE GLOBE
Pharmaceuticals | Biotech | Biosimilars
IPD's Life-Cycle Insights subscription serves as the foundation of our unmatched visibility into the life cycle of drugs and biologics, from early-stage pipeline assets to mature, established products.
Brand, generic, and biosimilar launches
Innovative product pipeline tracking
Litigation analysis and forecasted outcomes
Our team of former patent litigators, former Federal Circuit Clerks, PhD scientists, and patent researchers analyze public and proprietary data to provide summarized, comprehensive, strategic, and tactical analysis and insights.
Our Life-Cycle Insights cover:
Europe (France, Germany, Spain, Italy, United Kingdom)
Our subscribers gain around-the-clock access to IPD's proprietary web-based platform with real-time email alerts and expert consultations.
Data and analysis covering thousands of drugs and biologics in all major disease states and indications
Brand, generic, and biosimilar launch tracking tools to monitor new market entrants to the market and their impact on product pricing
Loss-of-exclusivity forecasts, patent information, regulatory data, generic-filer information, disease-area overviews, competitive intelligence, and drug pipelines up to 10 years in the future
Information on pending litigation and regulatory proceedings such as court cases, hearings, and oppositions that affect launch timing, direct vs. indirect competitors, and marketplace shifts